Dimensional Fund Advisors LP Replimune Group, Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Replimune Group, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,165,455 shares of REPL stock, worth $5.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,165,455

Previous 949,872 22.7%

Holding current value

$5.31 Million

Previous $9.26 Million 16.91%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$6.92 - $10.38 $1.49 Million - $2.24 Million	215,583 Added 22.7%	1,165,455 $10.8 Million
Q1 2025 May 13, 2025	BUY	$9.75 - $14.31 $1.67 Million - $2.46 Million	171,709 Added 22.07%	949,872 $9.26 Million
Q4 2024 Feb 13, 2025	BUY	$10.54 - $14.93 $2.45 Million - $3.48 Million	232,822 Added 42.69%	778,163 $9.42 Million
Q3 2024 Nov 07, 2024	SELL	$8.09 - $11.23 $528,600 - $733,768	-65,340 Reduced 10.7%	545,341 $5.98 Million
Q2 2024 Aug 09, 2024	SELL	$5.01 - $9.46 $1.84 Million - $3.47 Million	-367,171 Reduced 37.55%	610,681 $5.5 Million
Q1 2024 May 10, 2024	SELL	$6.87 - $9.31 $2.37 Million - $3.21 Million	-345,117 Reduced 26.09%	977,852 $7.99 Million
Q4 2023 Feb 07, 2024	SELL	$6.75 - $16.18 $722,628 - $1.73 Million	-107,056 Reduced 7.49%	1,322,969 $11.2 Million
Q3 2023 Nov 09, 2023	BUY	$15.96 - $22.18 $2.32 Million - $3.23 Million	145,576 Added 11.33%	1,430,025 $24.5 Million
Q2 2023 Aug 09, 2023	BUY	$15.65 - $24.1 $3.25 Million - $5.01 Million	207,966 Added 19.32%	1,284,449 $29.8 Million
Q1 2023 May 12, 2023	BUY	$17.48 - $29.09 $6.13 Million - $10.2 Million	350,595 Added 48.3%	1,076,483 $19 Million
Q4 2022 Feb 09, 2023	BUY	$17.09 - $27.91 $1.34 Million - $2.19 Million	78,532 Added 12.13%	725,888 $19.7 Million
Q3 2022 Nov 10, 2022	BUY	$15.6 - $21.15 $2.72 Million - $3.69 Million	174,300 Added 36.85%	647,356 $11.2 Million
Q2 2022 Aug 12, 2022	BUY	$13.32 - $19.98 $1.71 Million - $2.57 Million	128,659 Added 37.36%	473,056 $8.27 Million
Q1 2022 May 13, 2022	BUY	$15.24 - $29.75 $1.71 Million - $3.33 Million	111,920 Added 48.14%	344,397 $5.85 Million
Q4 2021 Feb 09, 2022	BUY	$25.43 - $34.25 $1.45 Million - $1.96 Million	57,117 Added 32.57%	232,477 $6.3 Million
Q3 2021 Nov 12, 2021	BUY	$28.98 - $39.54 $3.12 Million - $4.26 Million	107,808 Added 159.59%	175,360 $5.2 Million
Q2 2021 Aug 12, 2021	BUY	$28.5 - $39.37 $975,897 - $1.35 Million	34,242 Added 102.8%	67,552 $2.6 Million
Q1 2021 May 14, 2021	BUY	$30.22 - $45.57 $13,719 - $20,688	454 Added 1.38%	33,310 $1.02 Million
Q4 2020 Feb 25, 2021	BUY	$23.5 - $52.65 $772,116 - $1.73 Million	32,856 New	32,856 $1.26 Million

Others Institutions Holding REPL

# of Institutions

196

Shares Held

77.7M

Call Options Held

2.06M

Put Options Held

2.86M

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $225M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Replimune Group, Inc. Transaction History